AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2020
Jun 25, 2020
32853_dirs_2020-06-25_d8e3879d-f05a-4dbb-a4e1-18bdbb2d13a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2020-06-23
Reporting Person: Clague Laura (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-23 | Common Stock | A | 13369 | — | Acquired | 27356 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-06-23 | Stock Option (Right to Buy) | $3.74 | A | 20993 | Acquired | 2030-06-23 | Common Stock (20993.0) | Direct |
Footnotes
F1: Represents Restricted Stock Units that vest in full on the earlier to occur of June 23, 2021 and one day prior to the date of the Company's next annual meeting of stockholders. The Reporting Person has deferred settlement of the Restricted Stock Units until the earlier to occur of the Reporting Person's termination of service and a change of control.
F2: Represents Restricted Stock Units with respect to which the Reporting Person has deferred settlement as described above.
F3: The Option becomes exercisable in twelve equal monthly increments beginning on July 23, 2020.